Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study

BACKGROUND: We previously showed that the 10-year cardiovascular disease (CVD) risk threshold to initiate statins for primary prevention depends on the baseline CVD risk, age, sex, and the incidence of statin-related harm outcome and competing risk for non-CVD death. As these factors appear to vary...

Descripción completa

Detalles Bibliográficos
Autores principales: Yebyo, Henock G., Zappacosta, Sofia, Aschmann, Hélène E., Haile, Sarah R., Puhan, Milo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495829/
https://www.ncbi.nlm.nih.gov/pubmed/32942999
http://dx.doi.org/10.1186/s12872-020-01697-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495829/
https://www.ncbi.nlm.nih.gov/pubmed/32942999
http://dx.doi.org/10.1186/s12872-020-01697-6

Ejemplares similares